American Journal of Neuroradiology 21:357-366 (2 2000)
© 2000 American Society of Neuroradiology
ARTICLE
Comparison of Relative Cerebral Blood Volume and Proton Spectroscopy in Patients with Treated Gliomas
a From the Departments of Radiology (R.G.H., D.B.V., N.J.F., P.E.G., M.R.D., S.M.N., J.M.S-L., L.L.W., W.P.D., S.J.N.) and Neurosurgery (S.M.C.), University of California at San Francisco; and the Graduate Group in Bioengineering (D.B.V., S.M.N., S.J.N.), University of California, San Francisco and Berkeley.
BACKGROUND AND PURPOSE: Elevated relative regional cerebral blood volume (rCBV) reflects the increased microvascularity that is associated with brain tumors. The purpose of this study was to investigate the potential role of rCBV in the determination of recurrent/residual disease in patients with treated gliomas.
METHODS: Thirty-one rCBV studies were performed in 19 patients with treated gliomas. All patients also had proton MR spectroscopy and conventional MR imaging. Regions of abnormality were identified on conventional MR images by two neuroradiologists and compared with rCBV and MR spectroscopic data. Metabolites and rCBV were quantified and compared in abnormal regions.
RESULTS: In high-grade tumors, rCBV values were proportional to choline in regions of tumor and nonviable tissue. Although the presence of residual/recurrent disease was often ambiguous on conventional MR images, the rCBV maps indicated regions of elevated vascularity in all low-grade tumors and in 12 of 17 grade IV lesions. Regions of elevated and low rCBV corresponded well with spectra, indicating tumor and nonviable tissue, respectively.
CONCLUSION: This study suggests that rCBV maps and MR spectroscopy are complementary techniques that may improve the detection of residual/recurrent tumor in patients with treated gliomas. Compared with the spectra, the rCBV maps may better reflect the heterogeneity of the tumor regions because of their higher resolution. The multiple markers of MR spectroscopy enable better discrimination between normal and abnormal tissue than do the rCBV maps.
This article has been cited by other articles:
 |
|
 |
|
  I-C CHIANG, T-J HSIEH, M-L CHIU, G-C LIU, Y-T KUO, and W-C LIN Distinction between pyogenic brain abscess and necrotic brain tumour using 3-tesla MR spectroscopy, diffusion and perfusion imaging Br. J. Radiol., October 1, 2009; 82(982): 813 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Gasparetto, M. A. Pawlak, S. H. Patel, J. Huse, J. H. Woo, J. Krejza, M. R. Rosenfeld, D. M. O'Rourke, R. Lustig, E. R. Melhem, et al. Posttreatment Recurrence of Malignant Brain Neoplasm: Accuracy of Relative Cerebral Blood Volume Fraction in Discriminating Low from High Malignant Histologic Volume Fraction Radiology, March 1, 2009; 250(3): 887 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.K. Ellika, R. Jain, S.C. Patel, L. Scarpace, L.R. Schultz, J.P. Rock, and T. Mikkelsen Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1981 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chawla, S. Wang, R.L. Wolf, J.H. Woo, J. Wang, D.M. O'Rourke, K.D. Judy, M.S. Grady, E.R. Melhem, and H. Poptani Arterial Spin-Labeling and MR Spectroscopy in the Differentiation of Gliomas AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1683 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.M. Lupo, S. Cha, S.M. Chang, and S.J. Nelson Analysis of Metabolic Indices in Regions of Abnormal Perfusion in Patients with High-Grade Glioma AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1455 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ricci, A. Bacci, V. Tugnoli, S. Battaglia, M. Maffei, R. Agati, and M. Leonardi Metabolic Findings on 3T 1H-MR Spectroscopy in Peritumoral Brain Edema AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1287 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Torigian, S. S. Huang, M. Houseni, and A. Alavi Functional Imaging of Cancer with Emphasis on Molecular Techniques CA Cancer J Clin, July 1, 2007; 57(4): 206 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Spampinato, J. K. Smith, L. Kwock, M. Ewend, J. D. Grimme, D. L. A. Camacho, and M. Castillo Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial Tumors Am. J. Roentgenol., January 1, 2007; 188(1): 204 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Butowski, P. K. Sneed, and S. M. Chang Diagnosis and Treatment of Recurrent High-Grade Astrocytoma J. Clin. Oncol., March 10, 2006; 24(8): 1273 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cha Update on Brain Tumor Imaging: From Anatomy to Physiology AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 475 - 487. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lupo, S. Cha, S. M. Chang, and S. J. Nelson Dynamic Susceptibility-Weighted Perfusion Imaging of High-Grade Gliomas: Characterization of Spatial Heterogeneity AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1446 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, D. B. Vigneron, S. Cha, E. E. Graves, F. Crawford, S. M. Chang, and S. J. Nelson Relationship of MR-Derived Lactate, Mobile Lipids, and Relative Blood Volume for Gliomas in Vivo AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 760 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. M. Maia Jr, S. M. F. Malheiros, A. J. da Rocha, C. J. da Silva, A. A. Gabbai, F. A. P. Ferraz, and J. N. Stavale MR Cerebral Blood Volume Maps Correlated with Vascular Endothelial Growth Factor Expression and Tumor Grade in Nonenhancing Gliomas AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 777 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Covarrubias, B. R. Rosen, and M. H. Lev Dynamic Magnetic Resonance Perfusion Imaging of Brain Tumors Oncologist, September 1, 2004; 9(5): 528 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Uematsu, M. Maeda, N. Sadato, T. Matsuda, Y. Ishimori, Y. Koshimoto, H. Kimura, H. Yamada, Y. Kawamura, Y. Yonekura, et al. Blood Volume of Gliomas Determined by Double-Echo Dynamic Perfusion-Weighted MR Imaging: A Preliminary Study AJNR Am. J. Neuroradiol., November 1, 2001; 22(10): 1915 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, S. Cha, E. A. Knopp, G. Johnson, J. Arnett, and A. W. Litt High-Grade Gliomas and Solitary Metastases: Differentiation by Using Perfusion and Proton Spectroscopic MR Imaging Radiology, March 1, 2002; 222(3): 715 - 721. [Abstract] [Full Text] [PDF]
|
|